UK first in Europe to approve Valneva's easy-store COVID-19 vaccine
The UK was the first European country to approve the vaccine from French firm Valneva
The UK has approved a new COVID-19 vaccine from French biotech Valneva that is easier to store than market rivals and involves a process widely used in making flu and polio vaccines.
The VLA2001 vaccine is whole-virus inactivated, meaning the virus is grown in a lab and then made completely inactive so that it cannot infect cells or replicate in the body, but can still trigger an immune response. It received conditional marketing authorisation from the UK medicines regulator on Thursday for use by people aged 18-50.
Unlike many other COVID-19 vaccines which require ultra-cold storage, VLA2001 can be stored in temperatures achievable with a domestic refrigerator.
The European Medicines Agency’s human medicines committee (CHMP) initiated a rolling review of VLA2001 in December, 2021 and is expected to come to a decision this month. Valneva said in March that it expects a positive EMA recommendation, adding it has started manufacturing and has inventory ready for labelling and deployment once approved.
The company signed an advance purchase agreement with the European Commission for up to 60 million doses in November last year, with plans to deliver 24.3 million doses during the second and third quarters of 2022.
If approved, the shot would be the first inactivated whole-virus vaccine against COVID-19 in Europe. The technology has been used for decades, including in some vaccines against polio, influenza as well as the hepatitis A. Some view it as having the potential to appeal to those wary of new mRNA technology.
The vaccine was granted emergency use authorization by Bahrain’s health regulator at the beginning of March, having also signed an advance purchase agreement.
Related News
-
News Pharmapack Awards 2024 Patient-Centric Design Award Winner – Dr Ferrer BioPharma
The 2024 Pharmapack Awards celebrated the best in innovation and design for the pharmaceutical packaging and drug delivery industry on January 24, 2024. -
News Women in Pharma: Minding the Gap at Pharmapack 2024
2024 marks the first year Pharmapack will host a Diversity track dedicated to bridging the gap within the pharmaceutical packaging and drug delivery sector. The track includes a panel discussion on 'Enabling Diversity in the Workplace,' focused... -
News Pharmapack Awards 2024 - Celebrating Packaging and Drug Delivery Innovation
The 2024 Pharmapack Innovation Awards ceremony celebrated the best in pharmaceutical packaging and drug delivery innovation at all levels. The awards were held on January 24, 2024 at the Paris Expo Porte de Versailles. -
News 2024 Pharma Industry Trends Outlook: Collaboration, Market Maturity, and Digital Futures
The annual CPHI Online 2024 Pharma Trends Outlook, in partnership with Arvato Systems, identifies 12 key industry trends shaping the life sciences industry in the coming year. -
News New Novo Nordisk AI hub for drug discovery to open in London, UK
Danish pharmaceutical giant Novo Nordisk will be opening an AI-based research facility in the heart of London to advance drug discovery operations. -
News BioNTech to begin mRNA vaccine manufacturing in Rwanda by 2025
German biotechnology company BioNTech has stated their intentions to begin production at their mRNA vaccine factory in Rwanda by 2025, which will mark the first foreign mRNA vaccine manufacturing site on the continent of Africa. -
News Women in Pharma: Looking back on 2023 and moving forward to 2024
In this monthly series, we interview women from across the pharmaceutical industry and supply chain to discuss the importance of gender diversity in healthcare, the workplace, and beyond. -
News CPHI Barcelona 2023: Partnering for Success – Managing Outsourcing Relationships to Optimise Manufacturing Operations
During CPHI Barcelona 2023, insightful content sessions offered attendees the chance to explore trending topics with expert speakers and panellists. Here, we summarise what the pharma industry and supply chain are talking about the most.
Position your company at the heart of the global Pharma industry with a CPHI Online membership
-
Your products and solutions visible to thousands of visitors within the largest Pharma marketplace
-
Generate high-quality, engaged leads for your business, all year round
-
Promote your business as the industry’s thought-leader by hosting your reports, brochures and videos within your profile
-
Your company’s profile boosted at all participating CPHI events
-
An easy-to-use platform with a detailed dashboard showing your leads and performance